Message for the clinic
Pulmonary vein isolation (PVI) is established as the cornerstone for treating atrial fibrillation (AF). However, the low power longer duration (LPLD) ablation always accompanied by a higher recurrence and the clinical benefits of high power shorter duration (HPSD) ablation were inconsistent. In our analysis, we found that the approach of HPSD seen to be effective and safe for AF treatment.